A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise

NCT01809327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1186

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Canagliflozin 100 mg
DRUG: Canagliflozin 300 mg
DRUG: Metformin XR

Sponsor

Janssen Research & Development, LLC